Understanding how natural selection has shaped the genetic architecture of complex traits and diseases is of importance in medical and evolutionary genetics. Bayesian methods have been developed using individual-level data to estimate multiple features of genetic architecture, including signatures of natural selection. Here, we present an enhanced method (SBayesS) that only requires GWAS summary statistics and incorporates functional genomic annotations. We analysed GWAS data with large sample sizes for 155 complex traits and detected pervasive signatures of negative selection with diverse estimates of SNP-based heritability and polygenicity. Projecting these estimates onto a map of genetic architecture obtained from evolutionary simulations revealed relatively strong natural selection on genetic variants associated with cardiorespiratory and cognitive traits and relatively small number of mutational targets for diseases. Averaging across traits, the joint distribution of SNP effect size and MAF varied across functional genomic regions (likely to be a consequence of natural selection), with enrichment in both the number of associated variants and the magnitude of effect sizes in regions such as transcriptional start sites, coding regions and 5'-and 3'-UTRs.
Introduction
The joint distribution of SNP effect size and minor allele frequency (MAF) is an essential component of the genetic architecture of human complex traits and is influenced by natural selection 1 . A negative relationship between effect size and MAF is a signature of negative (or purifying) selection 2, 3 , which prevents mutations with large deleterious effects becoming frequent in the population. Understanding how natural selection has shaped genetic variation helps researchers to improve experimental designs of genetic association studies 4 and the estimation of SNP-based heritability (the proportion of phenotypic variance explained by the SNPs) [5] [6] [7] [8] . Inference on natural selection is also a critical step towards the understanding of the genetic architecture of complex traits. For instance, the theory of negative selection 9 explains why the effects of common variants identified by genome-wide association studies (GWAS) are unlikely to be large 10, 11 .
We have recently developed a Bayesian method (BayesS) to estimate the effect size-MAF relationship, which was considered as a free parameter (S) in the model 12 . We detected negative S for a number of complex traits in humans, highlighting an important role of negative selection in shaping the genetic architecture, consistent with the findings from other studies based on genome-wide variance estimation approaches 7, 10, 13, 14 . The BayesS model also allows us to estimate the SNP-based heritability and polygenicity (the proportion of SNPs with nonzero effects) to better describe the genetic architecture for a trait. The application of BayesS has been restricted to GWAS samples with individual-level genotypes but for most common complex diseases, only summary-level data are available. Moreover, despite the implementation of parallel computing strategy 12 , it remains computationally challenging to run BayesS for a biobank-scale data set, as the computing resource increase linearly with the number of individuals or SNPs.
In this study, we enhanced the BayesS model such that the analysis only requires GWAS summary statistics for the trait of interest and a sparse linkage disequilibrium (LD) correlation matrix from a reference sample. Our new method (referred to as Summary-data-based BayesS or SBayesS) opens an unprecedented opportunity to simultaneously estimate the genetic architecture, the parameter S (signature of natural selection) and joint SNP effects using publicly available data sets of the largest sample sizes to date. Given the GWAS summary statistics and the sparse LD matrix, it only takes a few hours for analysis with over a million SNPs regardless of the discovery sample size, merely a small fraction of the computational resource required for BayesS. Furthermore, we incorporated functional genomic annotations into the analysis by allowing the distributions of SNP effects to be different among annotation categories (e.g., coding, regulatory, and conserved regions). Compared to other methods utilising functional annotations, such as S-LDSC 15 , BayesRC 16 and RSS-E 17 , a unique feature of the annotation-stratified SBayesS (referred to as SBayesS-strat) is that it allows the estimation of S in each specific functional annotation category. We performed extensive analyses to benchmark between SBayesS and BayesS, and applied the SBayesS methods to GWAS summary statistics from the full release of the UK Biobank 18 (UKB) data and other published studies [19] [20] [21] [22] [23] [24] [25] [26] [27] , followed by time-forward simulations 28 to facilitate interpretation of the results.
Results

Method overview
BayesS is a method that can estimate three key parameters to describe the genetic architecture of complex traits by a Bayesian mixed linear model 12 Supplementary Fig. 1 ). However, it is impractical to store pairwise LD correlations of all genome-wide SNPs in the computer memory and not always feasible to access individual-level genotypes of the GWAS sample. We propose to compute pairwise LD correlations between SNPs located on the same chromosome from a reference sample and remove correlations that can be attributed to sampling variation by a chi-squared test, resulting in a sparse LD matrix (Methods To better understand the variability of regional genetic architecture in different parts of the genome, we incorporate functional genomic annotations into SBayesS to allow the three key parameters to vary in different annotation categories (Methods). The functional annotations, such as coding, regulatory and repressed regions, were obtained from the LDSC baseline model 14 (URLs), where the majority of SNPs (79%) have more than one annotation. To account for the overlap between annotation categories, a SNP that has multiple annotations is assumed to have a mixture of effect distributions, each specific to an annotation category, with the mixing probability a priori being one divided by the total number of annotations at the SNP. Note that the effect distribution for an annotation itself is a mixture distribution according to the BayesS prior. Thus, the annotation-stratified SBayesS is a double mixture model. During MCMC sampling, the enrichment of a parameter in an annotation category is computed as the ratio of the sampled value of the parameter in the category to that in the whole genome (Methods). In addition to per-SNP heritability, polygenicity and S, we are also interested in the enrichment of per-nonzero-effect (per-NZE) heritability (defined as ℎ "#$ % divided by the number of nonzero effects in the category), which is helpful to understand whether the enrichment of ℎ "#$ % in a genomic region is due to the larger number of associated variants or the larger magnitude of effect size compared to average.
Benchmarking SBayesS with BayesS
We used the UKB data to evaluate the performance of SBayesS by comparing the results to those from BayesS for common variants. We ran both SBayesS and BayesS with ~1.1 million HapMap3
SNPs with MAF ³ 0.01 for 18 quantitative traits as analysed in Zeng et al. 12 (n>100k). We used the HapMap3 SNPs as they were optimised to tag common genetic variants 30 and are widely used in the literature which improves the comparability of our results with those generated using published GWAS summary statistics. For ease of computation, we used unrelated individuals of European ancestry from the interim release of the UKB data for the BayesS analysis (maximum n=120k across traits) and the same data to generate GWAS summary statistics for the SBayesS analysis. In a random sample of 50k unrelated individuals from the full UKB cohort (n=350k), we computed a sparse LD matrix for the HapMap3 SNPs with a threshold chi-squared value of 10, equivalent to a r 2 threshold of 2´10 -4 given the sample size (Methods).
This resulted in each SNP, on average, being in LD with ~1,000 SNPs on the same chromosome.
We show in Fig. 1 that the consistency between the SBayesS and BayesS estimates for all of the three genetic architecture parameters is high across traits (Pearson correlation r=0.998 for Supplementary Fig. 4 ). Nevertheless, SBayesS was always consistent with BayesS regardless of the SNP panel used ( Supplementary Fig. 3 ).
Regarding the LD reference, when the LD reference sample size decreased from 50k to 20k, the differences in parameter estimates were negligible ( Supplementary Fig. 5 ). When the LD reference sample size further decreased to 4k, we observed notable inflation in the estimates of ℎ "#$ % and S, suggesting that the LD reference sample size cannot be too small relative to the GWAS sample size (Methods). Given a constant reference sample size (nref=50k), we ran GWAS with sample sizes ngwas=120k and 350k and found good concordance between SBayesS and BayesS in both cases ( Supplementary Fig. 6 ). As expected, the & estimate from either SBayesS or BayesS increased when a larger ngwas was used because of the increased power to detect small effects. Furthermore, with both nref=50k and ngwas=300k held constant, we benchmarked BayesS and SBayesS in a few different scenarios where the LD reference was a subset of the GWAS sample, an independent sample from the same population, or an independent sample from a slightly different population (i.e., the Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort; URLs). When the GWAS and LD reference samples were from the same population, the differences between BayesS and SBayesS were negligible ( Supplementary Fig.   7 ), suggesting that the performance of SBayesS is almost independent of the overlap between the GWAS and LD reference samples as long as they are from the same population. When the GERA cohort was used as the reference sample for the UKB GWAS data, a small inflation was observed in the estimates of S, likely because of the difference in ancestry between the UKB and GERA. This observation demonstrates the importance of choosing a reference sample that is genetically as close to the GWAS sample as possible in the analysis of summary data. Finally, we tested the method in application to ascertained case-control data by simulation. The parameter estimates were nearly unbiased regardless of whether cases were oversampled, although the sampling variances of the estimates of polygenicity and S were relatively large in some simulation scenarios where the number of cases was relatively small ( Supplementary Fig. 8 ).
Analyses of GWAS summary data from the UK Biobank and other published studies
We applied SBayesS to analyse the full release of the UKB data (URLs), including 26 complex traits and 9 common diseases (Supplementary Table 1 We also applied SBayesS to data for 9 other complex common diseases from published GWAS of very large sample size where only summary statistics are available (Supplementary Table 2 ). In the analysis of the UKB data, we used the sparse LD matrix computed from 50k individuals (a random subsample of all the UKB unrelated individuals as described above). For the analysis of data from published GWAS of which nearly all the samples are of European ancestry, the GERA sample was used as the LD reference. To mitigate the problem due to inconsistent LD between the GWAS and reference samples, we excluded SNPs in the major histocompatibility complex (MHC) region. The SNP-based heritability estimates for the diseases were converted to those on the liability scale following the method in Lee et al 31 .
On average across the 44 complex traits (including diseases), 1.8% of the 1.1 million common
HapMap3 SNPs explained 18% of the phenotypic variance ( Fig. 2 and Supplementary Table 1- 2). The estimate of SNP-based heritability for height was 0.545 (p.s.e.=0.003), consistent with those in previous studies using different approaches and data sets 6, 13, [32] [33] [34] . The most polygenic traits (i.e., body fat percentage, educational attainment and schizophrenia) had about 5% (~55,000) SNPs with nonzero effects. The least polygenic traits were prostate cancer, age at menopause and male pattern baldness, which were affected by about 0.1-0.3% (1,000-3,000) common SNPs. The estimate of S was significantly negative (P<0.001) in all the traits analysed, suggesting a pervasive action of negative selection on the trait-associated variants.
Interestingly, most traits had an estimate of S at about -0.6 (median=-0.578, SD=0.096), which motivated us to further investigate the interpretation of ' ( with respect to natural selection (see below). There were some traits for which ' ( was not significant in previous analysis based on individual-level genotypes and array SNPs 12 (e.g., T2D, fluid intelligence and neuroticism score) but became significant in the current study, likely because of the increased sample size that improved the detection power ( Supplementary Fig. 6 ). We also re-ran the analysis for the 9 public GWAS data sets with the UKB subsample as the LD reference and found that the results were highly consistent with those using LD from the GERA ( Supplementary Fig. 9 ).
We broadly classified the 44 traits into five categories related to disease, fertility, cardiorespiratory, anthropometry and cognition. The estimates of the genetic architecture parameters varied across traits and appeared to have distinct patterns in different categories substantially higher than that for other types of disease and comparable to those for the cognitive traits, consistent with the high polygenicity for brain-related traits reported in previous studies 10, 35 . The estimate of |S| was the highest for diseases, especially cardiovascular disease, and fertility traits, and the lowest for cognitive traits, with a relatively large variability in ' ( for diseases.
To investigate the diversity of genetic architecture in more traits, we applied SBayesS to GWAS summary data from the Neale Lab (URLs) for 274 quantitative traits in the UKB, among which 130 passed the convergence test (the failed ones were mainly due to the smaller sample sizes; mean n = 231k for converged and 73k for not converged) and 110 were not included in the analyses above ( Supplementary Table 3 ). Given the evolutionary parameters used in the forward simulation, we observed a variety of patterns of genetic architecture, which can be used as a map to infer the underlying evolutionary parameters in real traits. We then projected the observed genetic architecture of the 44 complex traits and diseases onto the map generated from the forward simulation ( Fig. 4 ).
The projection was done by minimizing the sum of the differences in internal angles between the two "triangles" (the observed versus the simulated genetic architecture) (Methods). Our projection shows that although the variation of ' ( was small among traits, different traits had diverse strength of negative selection on the associated variants. No trait was projected to the bottom left of the map where both per-variant heritability and strength of selection were relatively low, or the top right of the map where the selection was so strong that most causal variants were rare or had been removed from the population. As a result, there was a negative correlation between per-variant heritability and strength of selection from the projected genetic architecture. This inverse relationship is reasonable given S, because variants of larger pervariant heritability are expected to receive higher selection pressure such that a strong signature would manifest itself even if the selection on the trait is not as strong as that on a trait with a higher polygenicity and/or lower heritability. According to the projection, SNPs associated with brain-related traits including cognition and psychiatric disorders were under relatively strong selection, and most common diseases tended to have relatively small mutational target size. When we projected the median estimates of the genetic architecture parameters for each trait category onto the map, we found relatively strong selection on genetic variants associated with cardiorespiratory and cognitive traits and relatively small mutational target size for diseases and fertility traits (Fig. 5a ). As a result, common variants associated with diseases showed the largest estimated effect variance, and those associated with cardiorespiratory and cognitive traits showed the smallest estimated effect variance (Fig. 5b) , consistent with the GWAS results where the average marginal effect size (in SD units) decreased from disease-to cognition-associated SNPs (Fig. 5c,d) . We further performed projections based on the simulations with a constant effective population size of 10,000 and did not observe a qualitative change on the conclusions ( Supplementary Fig. 10 and 11 ), suggesting a limited impact of demography on the formation of genetic architecture.
Analyses incorporating functional genomic annotations
The functional annotation categories used in our analysis were from the LDSC baseline model 14 .
We excluded continuous annotations and annotations with flanking windows, resulting in 21
annotation categories such as the coding, regulatory, repressed and conserved regions ( Supplementary Table 4 ), with a large proportion of overlap between categories ( Supplementary Fig. 12 ). We applied SBayesS-strat to the 35 UKB traits (including 9 diseases), and combined the parameter estimates across traits for each functional category based on a method that accounts for the phenotypic correlations between traits (Methods). In general, the fraction of ℎ "#$ % explained by each functional category was proportional to the size of the category (correlation=0.987; Supplementary Fig. 13 ). Repressed regions appeared to be an outlier with the estimated ℎ "#$ % significantly lower than its expectation. The correlation was even higher between the polygenicity and the size of functional category (correlation=-0.999),
suggesting that a functional category that explains a greater fraction of heritability tends to have a larger number of causal variants, consistent with the findings of O'Connor et al 10 Table 5 ). The per-NZE heritability showed the highest enrichment at TSS, followed by coding, 5'-UTR, 3'-UTR and conserved regions, and remarkable depletion in the repressed regions (Fig. 6a ). In addition, the enrichment in per-NZE heritability was proportional to the enrichment in polygenicity (correlation=0.982), suggesting that the larger per-SNP heritability in a functional category was not only because of the larger number of causal variants but also the larger effect sizes, confirmed by forward simulation ( Supplementary   Fig. 14) . The parameter S was enriched in the repressed, coding, 5'-UTR and conserved regions despite a large sampling variation in the estimated fold enrichment (Fig. 6b ). There was a negative correlation of -0.290 between the enrichments of S and per-NZE heritability, and the correlation decreased to -0.788 when the apparent outliers (i.e., the coding, 5'-UTR and conserved regions) were removed. The presence of a negative correlation could be because for biologically important regions, a fraction of the genetic variants has been under positive selection, which to some extent offsets the signature of negative selection. To test if the negative correlation was driven by any artificial effect, we applied the method to simulated data sets under the null model (no enrichment in genetic architecture parameters) and did not observe a significant correlation ( Supplementary Fig. 15 ). Although the coding and repressed regions had similar ' ( , the variance of effect sizes were different regardless of MAF ( Fig. 6c,d ), suggesting different distributions of effect sizes for SNPs in different functional genomic regions.
Discussion
We have developed an efficient summary-data-based method to estimate the joint distribution of effect sizes and MAF as well as SNP-based heritability, polygenicity and joint SNP effects. By analysing GWAS summary statistics from the public domain, we detected pervasive signatures of negative selection in the genetic architecture of a wide range of complex traits including common diseases ( Fig. 2 and 3 ). This means, assuming that most mutations are deleterious to fitness, mutations with larger effects on fitness are more likely to be eliminated or kept at lower Our projection results show that despite the narrowly distributed ' ( , the strength of selection varied substantially across traits ( Fig. 4) , assuming stabilising selection in action (as suggested by previous work 11, 40, 41 ). In general, diseases showed the smallest mutational target sizes, while cardiorespiratory and cognitive traits showed the strongest selection on the associated variants ( Fig. 5a ). As a result, common variants associated with diseases (heart, lung, and brain function)
presented the largest (smallest) effect sizes ( Fig. 5b-d ).
Our annotation-stratified analysis further revealed that negative selection has acted differentially on the genome, resulting in non-identical distributions of effect sizes between functional categories. The biologically important categories, such as the TSS, coding and 5'-UTR regions, had the highest enrichment in per-NZE heritability and polygenicity, whereas the repressed regions were depleted in both per-NZE heritability and polygenicity (Fig. 6 ). Previous studies have attributed the enrichment in per-SNP heritability to the larger number of causal variants in functional regions 10 . Here, we further highlighted the contribution of differences in effect sizes to the per-SNP heritability enrichment. The repressed regions were evidently enriched in ' ( and had smallest effect variance for common SNPs (Fig. 6 ), suggesting an apparent role of negative selection in constraining the frequency of mutations with large effect sizes in the repressed regions. This observation should not be too surprising given that chromatin repression represents a higher order functional domain and is enriched for evolutionarily conserved non-exonic sequences 42 . Coding and 5'-UTR regions were enriched for ' ( yet had largest effect variance for common SNPs. Our explanation is that in addition to negative selection, positive selection may have also played a role in these regions to drive the evolution of protein-coding genes such that SNPs with relatively large (favourable) effects could be common. Unfortunately, our method cannot distinguish negative from positive selection when both types of selection are in action.
There are several limitations in this study. First, we used HapMap3 common SNPs for analysis and extrapolated our inference on negative selection to unobserved rare variants. We expect that the signature that natural selection left in common variants would remain in rare variants.
Because the rare sequence variants are not fully available in the UKB, we investigated this hypothesis by forward simulation. As expected, the selection signature in rare variants followed similar patterns as that in common variants, but the magnitude of S was weaker ( Supplementary Fig. 16 ). This is because the very rare variants were mostly new mutations whose relationship between effect size and MAF had not yet been shaped by selection, which diluted the selection signals from the variants under selection ( Supplementary Fig. 17 ),
suggesting that the true S parameter is allelic age dependent and subject to the combined effect Supplementary Fig. 18 for a simulation study). The strong negative selection on BMI-associated variants inferred from our result is nevertheless consistent with a recent study 43 which showed a large proportion of variance explained by very rare variants (0.01%<MAF<0.1%) for BMI although the SE was large. We also performed a set of simulations with fixed environmental variance allowing the heritability to reach a mutation-selection-drift equilibrium. The results ( Supplementary Fig. 19 and 20) were comparable to those from the simulations with fixed heritability and variable environmental variance presented above ( Fig. 4 and 5a) . Third, independence of chromosomes is assumed in our model. This may not hold if there was non-random mating in the ancestral population. For example, assortative mating would introduce positive correlations between trait-increasing alleles located on different chromosomes, and therefore increase heritability in the equilibrium population, e.g. for height 44 . Our estimate of SNP-based heritability accounts for intra-chromosomal LD but ignored inter-chromosomal LD so that it is expected to be between the base and equilibrium population estimates. Further improvement is possible if the correct correlation matrix is used. Despite these limitations, our study highlights the impact of negative selection on the genetic architecture across complex traits and in different functional genomic regions. In addition to better understanding of the genetic architecture, our methods can also be applied to genetic mapping and polygenic risk prediction through the use of the joint SNP effect estimates or the characterised underlying distributions of effect sizes as prior knowledge for other methods 45 .
Methods
SBayesS
Let us consider an individual-level data-based multiple regression model for a GWAS cohort:
where y is the vector of phenotypes adjusted for all fixed effects, X is the column-centred In contrast to the identity structure of residual variance in model (1), the residuals in model (2) are dependent of LD, as
This is a generic form of summary-data-based Bayesian regressions, which is similar to Zhu and Stephens's RSS model 33 . As in BayesS, we assume the effect size is related to MAF through a parameter S:
where b is a point mass at zero, and S (the relationship between MAF and effect sizes), F% (the effect variance factor common to all SNPs) and π (the proportion of SNPs with nonzero effects, i.e., the polygenicity) are considered as unknown, with prior distributions of a standard normal, a scaled inverse chi-squared distribution (Supplementary Note), and a uniform distribution between zero and one, respectively. Specifying a different prior distribution to Z H gives a form of other summary-data-based Bayesian alphabet models 47 .
We show in the Supplementary Note that models (1) and (2) (2) allows us to incorporate LD information from a different reference sample from the GWAS sample for which the individual-level data are often not accessible. Further, it is often not practical to compute and store the entire LD matrix in the memory. Therefore, we used a sparse LD matrix that ignores the small LD correlation estimates that are due to sampling variation, but still accounted for the sampling variance of LD correlation in the model (see below). Once the LD matrix is computed, it can be used repeatedly in the GWAS summary-data analysis for different traits.
We used MCMC algorithm to generate 50,000 posterior samples (the first 20,000 discarded as where T is the chain length, W is the within-chain variance, and B is the between-chain variance.
To assess convergence in MCMC, we computed the potential scale reduction statistic v * = w BCD p (q|r) t
for each of the model parameters. As suggested by Gelman and Rubin, v * < 1.2 generally indicates good convergence. Thus, we concluded convergence for a trait analysis when all of the three genetic architecture parameters had v * < 1.2.
Sparse LD matrix
For computational efficiency, we used a sparse LD matrix in the analysis where LD due to sampling variation were set to be zero. To this end, we tested whether the LD between each pair of SNPs on the same chromosome is zero in the population when computing the LD correlation matrix using a reference sample. Under the null hypothesis that the true LD in the population is zero, we assume (ref 48 (tilde denotes quantities computed from the reference sample) and reject the null if the chisquared statistic > 10 (P<0.0016). This is equivalent to a r 2 threshold of 2×10 -4 given a sample size of 50,000. We set u z H{ to be zero if the null hypothesis is not rejected or if the two SNPs are on different chromosomes, leading to a sparse LD matrix. The chi-squared threshold of 10 is chosen in order to balance the type I and II error rates. If a type I error occurs, i.e., the true correlation ρjk=0 but u z H{ is not set to be zero, then as explained below, g H{ % =|
which is very likely to be larger than the true sampling variance of 1/njk. This would inflate the residual variance and therefore deflate the heritability estimate. If a type II error occurs, i.e. ρjk≠0 but u z H{ is set to be zero, then g H{ % = R Ä , which is very likely to be larger than the true sampling variance of
. This would deflate the residual variance and therefore inflate the heritability estimate. Since the consequence of type II errors is worse, we use a nottoo-stringent threshold to eliminate the LD due to sampling. This also suggests that LD reference sample size cannot be too small, otherwise, type II error rate would increase due to the loss of power. Since we only include non-zero elements in the LD matrix, it is faster by folds to run the summary-level data analysis with substantially less amount of memory needed.
Modelling LD sampling variance
The use of a sparse LD matrix from a reference sample will result in two sources of sampling variation. The first is the difference in sampling variance between the reference and GWAS samples for the LD correlations included in the sparse LD matrix. The second is the sampling variance of LD correlations that are set to be zero. As shown in the Supplementary Note, ignoring these sampling variations will result in a bias in the mean of the full conditional distribution of βj and thereby biases in the estimation of other model parameters. Here, we account for both sampling variations in the model, as described below.
Suppose that the observed LD correlation between SNP j and k equals to the true population LD plus a deviation, i.e., u H{ = Ç H{ + É H{ , or in the reference sample, u z H{ = Ç H{ + É Ñ H{ . Then, the LD 6) can be greater than the phenotypic variance of the trait.
SNP-based heritability estimation
In BayesS 12 , we computed the genetic variance F ê % as the variance of genetic values across individuals given the sampled values of ; in each MCMC iteration. As described in Zhu and
Stephens 33 , this is equivalent to the following quadratic term of ; given the LD correlation matrix: We further combined the information across traits by calculating the mean fold enrichment for each functional category. To account for the phenotypic correlation among the traits, we estimated the effective number of traits (ne) by performing an Eigen decomposition on the phenotypic correlation matrix, following the method described in ref 49 : where 'M p (q|r) is the standard deviation of the parameter estimate across traits.
Annotation-stratified SBayesS
O G = (∑ m
GWAS summary statistics
We performed GWAS analyses for 26 quantitative traits and 9 common diseases in the full release of the UKB data using PLINK where the slope 7 R is an estimate of S according to the BayesS model, and the residuals … are independent. We repeated this simulation process 30 times and computed the mean of each genetic architecture parameter in each of the scenarios.
To facilitate the projection of real-trait genetic architecture, we first mapped the genetic architecture parameters estimated from the simulated traits in a polar coordinate, with the estimates scaled by the respective maximum values across simulation scenarios to give the same range between zero and one for each parameter. Connecting the values in the polar coordinate manifested a triangle that was unique to a simulation scenario. Similarly, we mapped the estimated genetic architecture parameters for the real traits and formed a triangle by scaling each parameter estimate by the maximum value across traits. For each real trait, we then sought to project it onto the simulation scenario that had the most similar triangle by minimising the sum of the differences in internal angles between the two triangles. Although the point estimates of the genetic architecture parameters were used to form the triangle, it can be seen that the estimation variation did not have substantial effect on the shape of the triangle ( Supplementary Fig. 21 ). Finally, we computed the median values of the parameter estimates for each trait category, and projected them onto the map of genetic architecture using the same method. 
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